Blog | HemaCare

FDA Approves First Virus Inactivation Device for Plasma

Feb 23, 2015 1:00:27 PM / by Daisy posted in Ebola, INTERCEPT Blood System, blood-borne pathogen, convalescent plasma therapy, decontamination, Innovation


The INTERCEPT Blood System for plasma: an innovative safety net for medicine, a preemptive strike against new outbreaks.

Read More

Experimental Blood Therapy May Cure Ebola

Feb 9, 2015 1:00:56 PM / by Shweta posted in blood, antibodies, convalescent plasma therapy, research, virus, Whole Blood


Convalescent plasma therapy could be an effective treatment to fight against the Ebola virus

The Ebola virus causes a serious and deadly disease transmitted by animals and humans. The current Ebola epidemic is the largest outbreak in history, affecting many countries in West Africa. The Ebola virus likely originated in African fruit bats, but apart from zoonotic transmission it can also be transmitted from one human to another via direct contact such as through broken skin or mucous membranes, bodily secretions or fluids, or by contact with surfaces and materials (e.g. bedding, clothing) contaminated with these fluids. So far, no FDA-approved vaccine or medicine is available to treat Ebola infection. Only a few primary prevention measures are available which are largely based on symptomatic treatment and by avoiding direct contact with infected people and animals.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts